Related Experiment Video
Updated: Jul 3, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Vaccinia virus E3 protein prevents the antiviral action of ISG15
Susana Guerra1, Ana Cáceres, Klaus-Peter Knobeloch
1Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología CSIC, Campus Universidad Autónoma, Madrid, Spain. sguerra@cnb.csic.es
Abstract:
The ubiquitin-like modifier ISG15 is one of the most predominant proteins induced by type I interferons (IFN). In this study, murine embryo fibroblast (MEFs) and mice lacking the gene were used to demonstrate a novel role of ISG15 as a host defense molecule against vaccinia virus (VACV) infection. In MEFs, the growth of replication competent Western Reserve (WR) VACV strain was affected by the absence of ISG15, but in addition, virus lacking E3 protein (VVDeltaE3L) that is unable to grow in ISG15+/+ cells replicated in ISG15-deficient cells. Inhibiting ISG15 with siRNA or promoting its expression in ISG15-/- cells with a lentivirus vector showed that VACV replication was controlled by ISG15. Immunoprecipitation analysis revealed that E3 binds ISG15 through its C-terminal domain. The VACV antiviral action of ISG15 and its interaction with E3 are events independent of PKR (double-stranded RNA-dependent protein kinase). In mice lacking ISG15, infection with VVDeltaE3L caused significant disease and mortality, an effect not observed in VVDeltaE3L-infected ISG15+/+ mice. Pathogenesis in ISG15-deficient mice infected with VVDeltaE3L or with an E3L deletion mutant virus lacking the C-terminal domain triggered an enhanced inflammatory response in the lungs compared with ISG15+/+-infected mice. These findings showed an anti-VACV function of ISG15, with the virus E3 protein suppressing the action of the ISG15 antiviral factor.
Insights
The ubiquitin-like modifier ISG15 acts as a host defense against vaccinia virus (VACV). ISG15 deficiency enhances VACV replication and pathogenesis, with the virus E3 protein suppressing ISG15
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Type I interferons (IFN) induce ISG15, a ubiquitin-like modifier.
- ISG15's role in host defense against viral infections is under investigation.
Purpose of the Study:
- To investigate the role of ISG15 in host defense against vaccinia virus (VACV).
- To elucidate the mechanism of ISG15's antiviral activity against VACV.
Main Methods:
- Utilized ISG15-deficient murine embryo fibroblasts (MEFs) and mice.
- Employed vaccinia virus strains, including a deletion mutant (VVDeltaE3L).
- Used siRNA and lentivirus vectors to modulate ISG15 expression; performed immunoprecipitation analysis.
Main Results:
- ISG15 deficiency enhanced VACV replication and VVDeltaE3L growth in MEFs.
- ISG15-deficient mice exhibited increased disease and mortality upon VVDeltaE3L infection.
- VACV E3 protein binds ISG15 and suppresses its antiviral activity, independent of PKR.
- Enhanced lung inflammation observed in ISG15-deficient mice infected with VACV mutants.
Conclusions:
- ISG15 functions as a crucial host defense molecule against VACV infection.
- The viral E3 protein antagonizes ISG15's antiviral activity.
- ISG15 plays a significant role in controlling VACV pathogenesis and associated inflammation.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly
Inhibitors Of Virion Release
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Respiratory Syncytial Virus Disease
Leaky Scanning

